- Profile
- prev
- next
General
-
Headquarters
Berkeley, California, United States
-
Founders & Team
Marcel V. Alavi
-
Year Founded
2016
-
Company type
Private company
Technical Details
-
Aging Target
Mitochondrial dysfunction
-
Disease indication
Alzheimer's, cancer, glaucoma, and cardiovascular disease
-
Product modality
small molecule, drugs
-
Clinical stage
Pre-clinical
About
712 North is a pre-clinical stage pharmaceutical company based in California. We develop modulators of the dynamic mitochondrial network for a range of age-related diseases such as Alzheimer's, cancer, glaucoma, and cardiovascular disease. The mechanism of action ties the biology also to a rare pediatric indication with unmet medical need. We can leverage this orphan disease as fast to market strategy. Our goal is to become the global leader in innovative personalized mitochondrial medicines.